2018
DOI: 10.1111/pan.13444
|View full text |Cite
|
Sign up to set email alerts
|

The effect of xenon‐augmented sevoflurane anesthesia on intraoperative hemodynamics and early postoperative neurocognitive function in children undergoing cardiac catheterization: A randomized controlled pilot trial

Abstract: In this pilot trial, xenon-augmented sevoflurane anesthesia in school-aged children was feasible, and associated with decreased ephedrine requirements. All children exposed to anesthesia showed impaired neurocognitive performance in the immediate postoperative period when compared to control children; however, without significant differences between both treatment groups.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 32 publications
0
7
0
1
Order By: Relevance
“…We previously demonstrated in children with CHD that the addition of 60% xenon to sevoflurane resulted in a 60% reduction of the mean expiratory sevoflurane concentration of sevoflurane to achieve a comparable depth of anesthesia [11,12]. Moreover, we did find a decreased incidence of ED when xenon was added to sevoflurane anesthesia [11].…”
Section: Introductionmentioning
confidence: 68%
See 2 more Smart Citations
“…We previously demonstrated in children with CHD that the addition of 60% xenon to sevoflurane resulted in a 60% reduction of the mean expiratory sevoflurane concentration of sevoflurane to achieve a comparable depth of anesthesia [11,12]. Moreover, we did find a decreased incidence of ED when xenon was added to sevoflurane anesthesia [11].…”
Section: Introductionmentioning
confidence: 68%
“…The diagnosis of ED remains notoriously difficult in young children. For several reasons, we opted in this study (as we did in several previous ones) for the Watcha scale as an instrument to assess the incidence of ED in this young population [11,12,28]. In fact, the frequently used PAED scale was derived and validated in a cohort of children with a mean age of 3.7 years [23].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Different drugs are being studied to mitigate the apoptosis response to ASAs. Xenon and Dexmedetomidine (DEX) are already used in clinical settings as neuroprotection and anaesthetic sparing-effect, but more research is still needed [48][49][50][51].…”
Section: Discussionmentioning
confidence: 99%
“…Different drugs are being studied to mitigate the apoptosis response to ASAs. Xenon and Dexmedetomidine (DEX) are already used in clinical settings as neuroprotection and anaesthetic sparing-effect, but more research is still needed [47][48][49][50][51].…”
Section: Discussionmentioning
confidence: 99%